To isolate p53-associated proteins under physiological conditions, we modified the p53 gene using an AAV (adeno-associated virus)-based gene-targeting approach in HCT116 cells, a human colorectal cancer cell line that retains wild-type p53 [40]. This evidence concerns the gene TP53 and colorectal cancer.